Oliver Wyman Health Innovation Summit 2024

Feyi Olopade Ayodele is CancerIQ’s co-founder and CEO. In this role, Feyi is leading CancerIQ’s bold vision to end cancer as we know it by empowering providers and health systems to expand access to precision cancer prevention, early detection & treatment. CancerIQ makes it easy for health systems to use genetic information to get ahead of cancer at scale. Its best-in-class, science-based platform is proven to double genetic counseling service capacity, quadruple genetic testing uptake & significantly improve screening compliance. Under Feyi’s leadership, CancerIQ has grown its provider network to over 200 locations across the county and established a robust ecosystem of leading diagnostic, genomics testing, telehealth, and AI vendors. These efforts have enabled health systems to increase the use of preventive services, generate downstream revenue, improve quality and screening compliance, and shift cancer diagnoses to earlier stages. Concurrently, CancerIQ has helped its life sciences partners get their innovative, life-saving technologies into the hands of more providers. Most recently, Feyi was named a Modern Healthcare Innovator for 2024 and saw CancerIQ listed among the world’s best digital health companies by Newsweek. A trusted expert in the field of precision prevention, Feyi is routinely featured by prominent industry outlets and organizations including HLTH Matters, Forbes, TechCrunch, Health Management Academy, the Association of Cancer Executives, and more. In recognition of her success, Feyi was named to Crain’s Chicago Business 40 under 40 list in 2019 and has won multiple honors including a Chicago Innovation Award, the Chicago Booth New Venture Challenge, a fellowship from Rock health, and the Women Tech Founders Award. In 2022, Feyi closed CancerIQ’s Series B funding round, led by Merck Global Health Innovation Fund and Amgen Ventures, making her one of the most-funded Black female founders of the year. Feyi received both her bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse, respectively.

Edward Chang MD is Professor and Chair of Neurological Surgery at the University of California, San Francisco. Dr. Chang’s clinical expertise is surgical therapies for epilepsy and brain tumors. He specializes in advanced neurophysiologic brain mapping methods, including awake speech and motor mapping, to safely perform neurosurgical procedures in eloquent areas of the brain. His research focuses on the discovery of cortical mechanisms of high-order neurological function in humans. Dr. Chang’s laboratory has demonstrated the detailed functional organization of the human speech cortex and has translated those discoveries towards the development of a speech neuroprosthetic device to restore communication for people living with paralysis. Dr. Chang is recipient of the 2015 Blavatnik National Laureate in Life Sciences, The Winn Prize of the Society of Neurological Surgeons, and was elected to the National Academy of Medicine.

Alice Hm Chen, MD, MPH, serves as Chief Health Officer (CHO) for Centene Corporation. Dr. Chen is responsible for Centene's strategies, policies and programs in support of improving population health for Centene's members. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state’s health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity and delivery system transformation. She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the California Health and Human Services Agency, where she led signature health policy initiatives on affordability and access and played a leadership role in the state’s response to the COVID-19 pandemic. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. Dr. Chen received a Bachelor of Science in environmental biology from Yale University and has a Doctor of Medicine from the Stanford University School of Medicine. She also has a Master of Public Health in health care management and policy from Harvard School of Public Health. A primary care internist by training, she provides clinical care at Zuckerberg San Francisco General Hospital. Andreas ‘Drew’ Panayiotou joined Pfizer in September 2022 as the company’s first-ever Global Chief Marketing Officer. Drew is a seasoned and respected thought leader with nearly 30 years of global marketing experience across industries. He has led marketing at top companies including Johnson & Johnson, Hershey’s, The Coca-Cola Company, Chick-fil-A, Best Buy, The Walt Disney Company, and advertising agency BBDO.

Dr. Elizabeth Fowler is Deputy Administrator and Director of the Center for Medicare and Medicaid Innovation at CMS. Dr. Fowler previously served as Executive Vice President of programs at The Commonwealth Fund and Vice President for Global Health Policy at Johnson & Johnson. Before that, she was special assistant to President Obama on health care and economic policy at the National Economic Council. From 2008 to 2010, she was Chief Health Counsel to Senate Finance Committee Chair, Senator Max Baucus (D-MT), where she played a critical role developing the Senate version of the Affordable Care Act. She also played a key role drafting the 2003 Medicare Prescription Drug, Improvement and Modernization Act (MMA). Dr. Fowler has over 25 years of experience in health policy and health services research. She earned a bachelor’s degree from the University of Pennsylvania, a Ph.D. from the Johns Hopkins Bloomberg School of Public Health, and a law degree (J.D.) from the University of Minnesota. She is admitted to the bar in Maryland, the District of Columbia, and the U.S. Supreme Court. Dr. Fowler is a Fellow of the inaugural class of the Aspen Health Innovators Fellowship and was elected to the National Academy of Medicine in 2022.

Niyum Gandhi is the Chief Financial Officer and Treasurer at Mass General Brigham. His responsibilities include financial oversight for Mass General Brigham’s clinical and academic operations and management within the areas of corporate finance, treasury, managed care, real estate, and supply chain, as well as operational oversight of Mass General Brigham Health Plan. Prior to joining Mass General Brigham and returning to Boston in 2021, Niyum served on the executive team at Mount Sinai Health System in New York. He joined the organization as its first Chief Population Health Officer in 2015. In that role, he built Mount Sinai’s clinically integrated network, direct-to-employer business unit and consumer digital function. He later took on the role of Chief Financial Officer for the health system, overseeing the financial operations of Mount Sinai’s eight hospitals and the Icahn School of Medicine. Before his tenure at Mount Sinai, Niyum was a Partner in the Health and Life Sciences consulting practice of Oliver Wyman, a global management consulting firm, where he focused on financial planning, value-based health care, and transformation strategies for hospitals, physician groups, and health plans. Throughout his career, Niyum has collaborated closely with a variety of health care providers and payers to help design and implement value-based clinical models, develop new contracting and integrated product distribution strategies, align funds flow and physician incentives, and establish the appropriate infrastructure to support value-based health care. Niyum holds an A.B. in economics from Harvard University.

Bio coming soon!

Kim A. Keck is president and chief executive officer of the Blue Cross Blue Shield Association (BCBSA), a national federation of independent, community-based and locally operated Blue Cross and Blue Shield (BCBS) companies. Keck, a respected leader in the healthcare industry, has built a reputation as an engaged, incisive leader. As president and chief executive officer of BCSBA, Keck is focused on driving equity and affordability in health care. This focus has led to partnerships addressing the cost of prescription drugs and dedicated efforts to address the racial disparities in maternal healthcare. Prior to joining BCBSA in 2021, she served as president and CEO of Blue Cross & Blue Shield of Rhode Island (BCBSRI), the state’s largest health insurer. During her tenure at BCBSRI, she drove strategic initiatives around cost and value stewardship, convenience and comprehensive health, and led policy efforts fortifying elements of the Affordable Care Act to ensure all Rhode Islanders have access to quality care. She also combatted long-standing social issues influencing health outcomes, including childhood obesity, housing insecurity and racial inequities. Keck previously spent 28 years at Aetna, where she held leadership roles spanning from head of enterprise strategy to head of investor relations, treasury, tax, actuary, controllers and planning. She served as president of Aetna’s northeast region and interim president of the southeast region and was responsible for $20 billion in revenue and approximately five million members across the commercial and Medicare segments. As a prominent and innovative leader in the industry, Keck was named one of Modern Healthcare’s 100 Most Influential People in Healthcare for 2022 and was recognized on the Who’s Who list in 2023 by Crain’s Chicago Business. Keck graduated with honors from Boston College with a degree in mathematics and earned a Master of Business Administration in finance from the University of Connecticut. She is a CFA charter holder.

Andreas ‘Drew’ Panayiotou joined Pfizer in September 2022 as the company’s first-ever Global Chief Marketing Officer. Drew is a seasoned and respected thought leader with nearly 30 years of global marketing experience across industries. He has led marketing at top companies including Johnson & Johnson, Hershey’s, The Coca-Cola Company, Chick-fil-A, Best Buy, The Walt Disney Company, and advertising agency BBDO.

Ran is a Partner in Oliver Wyman’s Health & Life Sciences Practice, works across the Payer and Providers domains, specializing in the latter. He has spent the last 15 years in advising large care delivery providers, health insurers and new entrants to the industry. Relevant Experience •For a regional health system, Ran led the development of a multi-year strategy, centered on becoming a leading population health manager in the area, improving consumer experience and driving growth. As part of the work, the operating mode land the physician structure have been diagnosed and radically redesigned to align with PHM objectives. •A large regional provider was embarking on a volume to value transformation. The client needed a complete strategy development, integrating existing plans and capabilities into a 5-year roadmap plan. Ran had a key role in developing the client’s approach and strategy to re-design its primary and specialty care models to become a true population health manager •For a regional healthsystem, Ran developed a new design and implementation structure for its Independent Physician Association. The design included a differentiated value proposition for providers, a service and support model to the physicians and the financial structures required to fund the and incentivize efforts. •Ran led a comprehensive corporate strategy development for a top-tier regional health system that examined market positioning, market and external dynamics – current and future and charted several future market scenarios. The team then articulated a unique, differentiated value proposition for the client and a related growth strategy, aiming to drive significant growth in the face of declining reimbursements and increasing costs •For a regional health system, Ran led a service line business planning and operating model restructuring aimed to reduce cost and drive profitable growth. The plans included elements of footprint expansion and rationalization, independent provider partnership and alignment, scope of services updates, marketing and branding. In addition, a long-term revamped operating model and a hybrid accountability structure with hospital operations and medical group was put in place •For a suburban regional health system, Ran led an OW team which developed, in close collaboration with the client an innovative ‘new front door’ for the client, focused on a combination of physical and digital ambulatory access points across the communities served. These new modalities of care expanded on the traditional definition of ‘sick care’ to engage patients in their daily lives in a digital manner and provide them personalized access options on their terms •A regional health systems was facing challenging reimbursement and cost dynamics and required a significant change to its way of working to optimize its cost structure and ignite growth. Ran led a large team of consultants and clinical subject matter experts in diagnosing the current state of operations, followed by an intense, collaborative development of the future state and the implementation plan. The OW team left the client with a ready to implement and widely accepted plan to realize up to 5 percentage points improvement of its current operating margin within the next 3 years. Prior to Oliver Wyman, Ran spent 5 years working for Tefen Management Consulting in Israel and the US. Through global engagements across numerous industries, including Healthcare, Ran led project teams in the implementation of business process re-design and the achievement of Operational Excellence. Ran holds a BSc from Shenkar College of Engineering and Design in Israel and a Six Sigma Black Belt certification from the American Society of Quality. Prior to academic education, Ran served for 6 years in the Israeli Navy.